Janus-I Science, Inc.
A small R&D company developing sample-to-answer diagnostic assays that integrate rapid specimen preparation, nanopore sequencing, and computational analytics for near-patient, field-forward, and high-throughput laboratory use. Focus areas include pathogen-agnostic identification, host-response biomarker assays for differential diagnosis, and automation of end-to-end workflows for healthcare and health-security customers.
Industries
N/A
Products
Nanopore sequencing–based diagnostic assay (sample-to-answer)
A development-stage diagnostic assay that combines rapid specimen preparation, nanopore sequencing, and computational analytics to identify unknown viral and bacterial pathogens and report host-response biomarkers at or near the point of care.
Nanopore sequencing–based diagnostic assay (sample-to-answer)
A development-stage diagnostic assay that combines rapid specimen preparation, nanopore sequencing, and computational analytics to identify unknown viral and bacterial pathogens and report host-response biomarkers at or near the point of care.
Services
Development of sample-to-answer diagnostic workflows
Design and integration of specimen preparation, sequencing, and analysis into automated workflows suitable for laboratory and near-patient use.
Computational analysis and machine learning for clinical sequencing
Development of algorithms and analytics to interpret nanopore sequence data, match microbes to reference databases, and report actionable clinical results.
Assay development for host-response biomarkers
Identification and quantitative assay development for mRNA host biomarkers to enable rapid differential diagnosis and triage.
Development of sample-to-answer diagnostic workflows
Design and integration of specimen preparation, sequencing, and analysis into automated workflows suitable for laboratory and near-patient use.
Computational analysis and machine learning for clinical sequencing
Development of algorithms and analytics to interpret nanopore sequence data, match microbes to reference databases, and report actionable clinical results.
Assay development for host-response biomarkers
Identification and quantitative assay development for mRNA host biomarkers to enable rapid differential diagnosis and triage.
Expertise Areas
- Diagnostic assay development
- Nanopore sequencing applications
- Sample preparation and nucleic acid extraction
- Computational genomics and bioinformatics
Key Technologies
- Nanopore sequencing
- Rapid nucleic acid extraction
- Machine learning for biomarker classification
- RNA/DNA library preparation